Recent evidence suggests that decreased EphA5 expression is associated with nodal metastasis, advanced TNM stages and unfavorable prognosis in CRC, implicating EphA5 as a potential tumor suppressor (44). The gene discussed is EPHA5; the disease is colorectal carcinoma.